231. Alpha-1-antitrypsin deficiency Clinical trials / Disease details
Clinical trials : 93 / Drugs : 77 - (DrugBank : 8) / Drug target genes : 10 - Drug target pathways : 36
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02810327 (ClinicalTrials.gov) | February 2015 | 20/6/2016 | Alpha-1 Carrier Genomics Study | Alpha-1 Carrier Genomics Study | Alpha-1 Antitrypsin Deficiency;Emphysema;COPD;Smoking | Genetic: Genetic Sequencing | Medical University of South Carolina | CSL Behring | Completed | 18 Years | N/A | All | 117 | United States |